333 related articles for article (PubMed ID: 6151611)
21. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
[TBL] [Abstract][Full Text] [Related]
22. [Nitrite therapy of stenocardia].
Meesmann W; Amann L
Dtsch Med Wochenschr; 1971 Sep; 96(36):1444-9. PubMed ID: 4397998
[No Abstract] [Full Text] [Related]
23. [The effect of contrasting baths on the autonomic regulation of cardiac activity in patients with ischemic heart disease (stable stenocardia and postinfarct cardiosclerosis)].
Sorokina EI; Olefirenko VT; Sandakhmedova IV
Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (2):32-6. PubMed ID: 2385939
[No Abstract] [Full Text] [Related]
24. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
[No Abstract] [Full Text] [Related]
25. [Outpatient polyclinic observations on senzit in the treatment of ischemic heart disease].
Kokutsov A
Vutr Boles; 1990; 29(1):35-8. PubMed ID: 2396416
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of the antianginal efficacy of sustonit compared with other nitrate drug forms].
Metelitsa VI; Kokurina EV; Martsevich SIu; Urumbaev RK; Slastnikova ID
Ter Arkh; 1989; 61(8):27-30. PubMed ID: 2511641
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
Klinger D
Wien Med Wochenschr; 1987 Jun; 137(12):278-86. PubMed ID: 2887073
[TBL] [Abstract][Full Text] [Related]
28. [Comparative characteristics of the hemodynamic and antianginal actions of obzidan and albetol in patients with stenocardia].
Zaĭtseva VI; Sharaeva ML
Vrach Delo; 1988 Dec; (12):15-8. PubMed ID: 2907700
[No Abstract] [Full Text] [Related]
29. [Features of the course of silent myocardial ischemia and choice of therapeutic policy].
Syrkin AL; Smulevich AB; Drozdov DV; Drobizhev MIu; Pecherskaia MB
Klin Med (Mosk); 1996; 74(3):42-4. PubMed ID: 8926701
[No Abstract] [Full Text] [Related]
30. [Cardiac function during adrenergic beta receptor blockade in different types of angina pectoris and local reversible myocardial ischemia of varying duration (clinico-experimental studies)].
Ol'binskaia LI; Bragina GI; Litvitskiĭ PF
Ter Arkh; 1980; 52(5):50-4. PubMed ID: 6105728
[No Abstract] [Full Text] [Related]
31. [Prevention of the initial forms of ischemic heart disease].
Ianovskiĭ GV
Vrach Delo; 1980 Apr; (4):32-4. PubMed ID: 6104382
[No Abstract] [Full Text] [Related]
32. Exercise testing and training in coronary heart disease.
Detry JM
Rev Inst Hyg Mines (Hasselt); 1972; 27(1):5-82. PubMed ID: 4145546
[No Abstract] [Full Text] [Related]
33. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
34. [Results of a 10-year prospective study of patients with ischemic heart disease].
Iurenev AP; Lediashova GA; Lupanov VP; Rubanovich AI; Zhukova IM
Kardiologiia; 1990 Jun; 30(6):47-51. PubMed ID: 1976847
[TBL] [Abstract][Full Text] [Related]
35. [Effects of a new positive inotropic agent, OPC-8212 in patients with effort angina--comparison with beta-blocker, metoprolol].
Kinoshita H; Maruyama Y; Maehara K; Shimizu Y; Inoue K; Ito N; Takishima T; Takahashi T; San-ei ND
Kokyu To Junkan; 1988 Nov; 36(11):1199-203. PubMed ID: 2907819
[No Abstract] [Full Text] [Related]
36. [The pharmacodynamics of proxodolol when administered once and in a course of doses to patients with stenocardia of effort].
Petrov IN; Rumiantsev AS; Smirnov MV
Eksp Klin Farmakol; 1994; 57(3):54-7. PubMed ID: 7914123
[TBL] [Abstract][Full Text] [Related]
37. [Effectiveness of using prolonged-action nitrates in ischemic heart disease].
Kuz'ko NV
Vrach Delo; 1981 Sep; (9):24-7. PubMed ID: 6795823
[No Abstract] [Full Text] [Related]
38. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
[No Abstract] [Full Text] [Related]
39. [Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients].
Grigor'iants RA; Lupanov VP; Samoĭlenko LE; Lobova NM
Ter Arkh; 1984; 56(4):67-70. PubMed ID: 6427964
[No Abstract] [Full Text] [Related]
40. Clinical outcome studies of anti-anginal drug therapy for patients with stable coronary disease: an indication for clinical trials.
Parker JD
Eur Heart J; 1998 Aug; 19 Suppl I():I15-9. PubMed ID: 9743439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
